Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes by James C. Zimring,

Slides:



Advertisements
Similar presentations
Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.
Advertisements

Volume 42, Issue 2, Pages (February 2015)
by Peter Ruf, and Horst Lindhofer
An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma by Stephen D. Gillies, Yan Lan, Steven Williams,
Combination therapy for adult T-cell leukemia–xenografted mice: flavopiridol and anti-CD25 monoclonal antibody by Meili Zhang, Zhuo Zhang, Carolyn K. Goldman,
Notch signaling induces cytoplasmic CD3ϵ expression in human differentiating NK cells by Magda De Smedt, Tom Taghon, Inge Van de Walle, Greet De Smet,
High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors by Glaivy Batsuli, Wei Deng, John.
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Platelet depletion by anti-CD41 (αIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering.
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases.
by Rafijul Bari, Teresa Bell, Wai-Hang Leung, Queenie P
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1- Related Immune Thrombocytopenia  Michael Nardi, Stephen Tomlinson, M.Alba.
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages by Wei Xia, Andrew R. Hilgenbrink,
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide by Yoshinori Nagai, Rintaro Shimazu, Hirotaka.
Working together to block alloimmunization
by Jörg Hartleib, Nicola Köhler, Richard B. Dickinson, Gursharan S
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion by Yenan T. Bryceson, Michael E. March, Hans-Gustaf.
A role for the thiol isomerase protein ERP5 in platelet function
by Norman Nausch, Ioanna E
Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X by Vincent Muczynski, Amine Bazaa, Cécile Loubière, Amélie.
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Volume 7, Issue 2, Pages (August 1997)
Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo by Federica M. Marelli-Berg,
Interleukin-21 is a growth and survival factor for human myeloma cells
Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection by Richard J. Pleass, Solabomi A. Ogun, David.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies by Inés González-García,
Differential Effect of E-Selectin Antibodies on Neutrophil Rolling and Recruitment to Inflammatory Sites by Carroll L. Ramos, Eric J. Kunkel, Michael B.
by Éric Aubin, Réal Lemieux, and Renée Bazin
by Herbert Bosshart, and Ruth F. Jarrett
Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro by José Perdomo, Feng Yan,
by Anne-lie Ståhl, Lisa Sartz, and Diana Karpman
Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation by Eric Boilard, Guillaume Paré, Matthieu Rousseau, Nathalie.
by Jamie Honeychurch, Alison L. Tutt, Thomas Valerius, Ingmar A. F. M
Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1/CD301a by Kayoko Sato, Yasuyuki Imai,
A Strong Expression of CD44-6v Correlates With Shorter Survival of Patients With Acute Myeloid Leukemia by S. Legras, U. Günthert, R. Stauder, F. Curt,
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma by Edmund A.
Erratum Experimental Hematology
by Bindu Varghese, Adam Widman, James Do, Behnaz Taidi, Debra K
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo by Rukhsana.
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing.
Volume 25, Issue 3, Pages (March 2017)
Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.
Volume 6, Issue 4, Pages (October 2009)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Arming Cytokine-induced Killer Cells With Chimeric Antigen Receptors: CD28 Outperforms Combined CD28–OX40 “Super-stimulation”  Andreas A Hombach, Gunter.
Volume 44, Issue 3, Pages (March 2016)
by Kalpana Parvathaneni, and David W. Scott
by Cheryl L. Maier, Amanda Mener, Seema R. Patel, Ryan P
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
Volume 13, Issue 4, Pages (April 2013)
Elicited and steady-state transport of skin self-antigens in PYNOD-KO mice. Elicited and steady-state transport of skin self-antigens in PYNOD-KO mice.
Tom E. Williams, Shanmugam Nagarajan, Periasamy Selvaraj, Cheng Zhu 
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Epidermal Langerhans Cells Rapidly Capture and Present Antigens from C-Type Lectin- Targeting Antibodies Deposited in the Dermis  Vincent Flacher, Christoph.
Functional Assessment of Precursors from Murine Bone Marrow Suggests a Sequence of Early B Lineage Differentiation Events  Kim-Sue R.S Tudor, Kimberly.
T exosomes bind MAdCAM-1 via RA-increased integrin α4β7.
Volume 20, Issue 4, Pages (April 2004)
Volume 5, Issue 3, Pages (September 1996)
by Tadayuki Yago, Nan Zhang, Liang Zhao, Charles S
Volume 20, Issue 5, Pages (May 2012)
Volume 24, Issue 1, Pages (January 2016)
Volume 7, Issue 2, Pages (August 1997)
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies by Nadine Müller-Calleja, Svenja.
Formation of Antigenic Quinolone Photoadducts on Langerhans Cells Initiates Photoallergy to Systemically Administered Quinolone in Mice  Akihiro Ohshima,
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
by Fabian C. Verbij, Nicoletta Sorvillo, Paul H. P
Volume 20, Issue 6, Pages (June 2004)
Presentation transcript:

Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes by James C. Zimring, Chantel M. Cadwell, Traci E. Chadwick, Steven L. Spitalnik, David A. Schirmer, Tao Wu, Charles A. Parkos, and Christopher D. Hillyer Blood Volume 110(6):2201-2208 September 15, 2007 ©2007 by American Society of Hematology

Non hemolytic antigen loss is not a general property of murine RBCs Non hemolytic antigen loss is not a general property of murine RBCs. (A) C57BL/6 mice were passively immunized with polyclonal anti-HEL antiserum or an anti-HEL IgG fraction from polyclonal antiserum. Non hemolytic antigen loss is not a general property of murine RBCs. (A) C57BL/6 mice were passively immunized with polyclonal anti-HEL antiserum or an anti-HEL IgG fraction from polyclonal antiserum. Control mice received no antibody. Mice were then transfused with a mixture of mHEL RBCs labeled with DiI and C57BL/6 RBCs labeled with DiO. Peripheral blood was obtained at the indicated time points and survival of the RBCs was determined by flow cytometry. (B) C57BL/6 mice were injected with the 10F7 anti-hGPA monoclonal antibody. Control mice received an IgG anti-HEL monoclonal antibody. Mice were then transfused with a mixture of hGPA RBCs labeled with DiI and C57BL/6 RBCs labeled with DiO and RBC survival was monitored. (C-H) Peripheral blood from the mice in panel A was stained with polyclonal anti-HEL antiserum followed by fluorescently labeled anti–mouse IgG and anti-HEL staining was measured by flow cytometry. Error bars in panels A and B represent standard deviation (SD). This experiment was reproduced 3 times with similar results. Representative flow plots and histograms are shown. In panels C, E, and G, the numbers in the upper left and lower right quadrants represent the percentage of circulating transfused B6 or mHEL RBCs, respectively. The numbers in the upper right quadrants represent the ratio of mHEL RBCs to B6 RBCs. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology

Antigen loss occurs in multiple different murine strains. Antigen loss occurs in multiple different murine strains. C57BL/6, BALB/c or C3H mice were actively immunized with HEL/CFA. Mice were transfused with a mixture of mHEL RBCs labeled with DiI and C57BL/6 RBCs labeled with DiO. Four days after transfusion, peripheral blood was obtained and stained with polyclonal anti-HEL antiserum followed by fluorescently labeled anti–mouse IgG; anti-HEL staining was measured by flow cytometry. (A-C) Numbers in the upper left and lower right quadrants represent the percentage of circulating transfused B6 or mHEL RBCs, respectively. (D-F) B6 and mHEL histograms are shown individually and then overlaid. This experiment was reproduced 3 times with similar results. Representative flow plots and histograms are shown. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology

Individual monoclonal anti-HEL antibodies do not induce antigen loss. Individual monoclonal anti-HEL antibodies do not induce antigen loss. C57BL/6 mice were passively immunized with the indicated anti-HEL monoclonal antibodies. Control mice received no antibody. Mice were transfused with a mixture of mHEL RBCs labeled with DiI and C56BL/6 RBC labeled with DiO. Three days after transfusion, peripheral blood was obtained, stained with polyclonal anti-HEL antiserum followed by fluorescently labeled anti-mouse IgG, and anti-HEL staining was measured by flow cytometry. This experiment was reproduced 3 times with similar results. Representative flow plots and histograms are shown. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology

Antigen-loss requires the simultaneous binding of antibodies with different epitope specificities. Antigen-loss requires the simultaneous binding of antibodies with different epitope specificities. (A) C57BL/6 mice were injected with the indicated combinations of monoclonal antibodies. Mice were transfused with a mixture of mHEL RBCs labeled with DiI and C57BL/6 RBCs labeled with DiO. Six days after transfusion, peripheral blood was obtained and stained with polyclonal anti-HEL antiserum followed by fluorescently labeled anti–mouse IgG; anti-HEL staining was measured by flow cytometry. The combinations are arranged to maximize functional groupings of antibodies, and a complete table is presented that shows each condition twice but allows easier pattern analysis. Antigen loss is designated as “LOSS,” whereas no antigen loss is indicated by “ø.” The outcome of combining an antibody with itself, which is the same as injecting the antibody alone, was taken from the data with isolated antibodies in Figure 3. This experiment was reproduced in its entirety 2 times with identical results. Additional experiments tested smaller groups of antibody combinations with identical findings. (B) Each monoclonal antibody was directly conjugated to Alexa Fluor 647. mHEL RBCs were preincubated with the indicated unconjugated monoclonal antibodies followed by staining with the indicated conjugated antibodies. Blocking by unconjugated antibodies was measured by flow cytometry. Blocking in both directions is defined as epitope identity (I), failure to block as nonidentity (ø), and blocking in only one direction as partial identity (P). This experiment was reproduced 2 times with identical results. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology

Model for molecular differences when 2 antibodies simultaneously bind to distinct epitopes on a single surface antigen. Model for molecular differences when 2 antibodies simultaneously bind to distinct epitopes on a single surface antigen. (A,B) A single IgG monoclonal antibody recognizing an epitope that occurs once on a surface molecule forms antigen dimers, but not multimolecular complexes. (C) The combination of 2 antibodies recognizing 2 distinct epitopes doubles the number of antibodies bound but also leads to multimolecular crosslinking. (D) The combination of intact IgG and F(ab′)2 fragments, each of which recognizes different epitopes, also induces multimolecular crosslinking but does not have an increased number of exposed Fc domains compared with a single IgG monoclonal antibody. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology

The requirement for multiple antibodies binding different epitopes is not due to increased numbers of Fc domains on the RBC surface. The requirement for multiple antibodies binding different epitopes is not due to increased numbers of Fc domains on the RBC surface. A mixture of mHEL RBCs labeled with DiI and C57BL/6 RBCs labeled with DiO was incubated in vitro with the indicated monoclonal antibody and/or F(ab′)2 fragment combinations or PBS. After 30 minutes, the mixtures were transfused into C57BL/6 mice. Peripheral blood was obtained 3 days later, stained with polyclonal anti-HEL antisera followed by fluorescently labeled anti–mouse κ light chain, and anti-HEL staining was measured by flow cytometry. This experiment was reproduced 3 times with identical results. Representative histograms are shown. James C. Zimring et al. Blood 2007;110:2201-2208 ©2007 by American Society of Hematology